Delivery Order SPE2DB20D1100-SPE2DB24FB7V7
Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,626,104 Glimepiride 4 mg tablets. The firm-fixed-price delivery order, valued at $4,039.92, has an ultimate completion date of December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The award has a ceiling value of $2,985.41 and a period of performance through April 10, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,575.07 firm fixed-price delivery order is for 4,567,102,251 units of the drug Glimepiride 4 mg tablets. The contract has an ultimate completion date of January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,143.31 firm-fixed-price delivery order is for 4,567,632,423 tablets of the medication Glimepiride 4 mg. The contract has an ultimate completion date of March 20, 2025 and was awarded on March 19, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Glimepiride tablets. The contract has a total ceiling value of $3,366.65 and is set to expire on February 11, 2025. The award is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of 4 mg Glimepiride tablets to the Defense Logistics Agency (DLA). The $7,283.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,102.86, is a delivery order for 4,566,812,305 units of the drug Glimepiride 4 mg tablets. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,140,931 units of the generic pharmaceutical product Glimepiride 4 mg tablets in 100-count bottles. The $2,229.27 firm fixed-price contract has a completion date of February 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $1,711.76 and a completion date of June 18, 2025. This is a Firm Fixed Price Delivery Order contract, which is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order has a firm fixed price of $1,600.28 and an ultimate completion date of August 15, 2024. The contract is for the supply of 4,565,454,389 glimepiride 4 mg tablets, a generic pharmaceutical product, to support government healthcare programs. This contract award is associated with a larger Indefinite Delivery Contract...